Difficulty: Medium
Average Score: 78%
Practice
The pathophysiologic basis for antiparkinsonism therapy is:
Correct answer
A
Rationale
Antiparkinsonism therapy targets the selective loss of dopaminergic neurons in the substantia nigra, which disrupts the balance between dopamine and acetylcholine in the basal ganglia. Treatments aim to restore dopamine levels or reduce cholinergic overactivity, making 'A selective loss of dopaminergic neurons' the correct pathophysiological basis.